MetLife Files 8-K with Financial Statements

TL;DR

MetLife filed an 8-K on 9/15/25, mostly financial docs. No major news.

AI Summary

On September 15, 2025, MetLife, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no specific material events or other significant business updates detailed in the provided text. The report confirms MetLife's principal executive offices are located at 200 Park Avenue, New York, NY 10166-0188.

Why It Matters

This filing provides updated financial information and exhibits for MetLife, Inc., which is crucial for investors and analysts to assess the company's financial health and performance.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of financial statements and exhibits, not indicating any new or unusual risks.

Key Players & Entities

• METLIFE, INC. (company) — Registrant
• September 15, 2025 (date) — Date of report
• 200 Park Avenue, New York, NY 10166-0188 (address) — Principal Executive Offices

FAQ

Key Financial Figures

• $0.01 M — ich registered Common Stock, par value $0.01 MET New York Stock Exchange Floating Rat
• $53.00 — pany's common stock. The offer price of $53.00 per share is approximately 34.42 percen
• $80.82 — roximately 34.42 percent lower than the $80.82 per share closing price for the Company

Filing Documents

• met-20250915.htm (8-K) — 33KB
• ex991newsrelease091525.htm (EX-99.1) — 12KB
• metlogo20202a02.jpg (GRAPHIC) — 25KB
• 0001099219-25-000219.txt ( ) — 247KB
• met-20250915.xsd (EX-101.SCH) — 2KB
• met-20250915_def.xml (EX-101.DEF) — 16KB
• met-20250915_lab.xml (EX-101.LAB) — 29KB
• met-20250915_pre.xml (EX-101.PRE) — 17KB
• met-20250915_htm.xml (XML) — 6KB

01 Other Events

Item 8.01 Other Events. MetLife, Inc. (the "Company") has received notice of an unsolicited "mini-tender" offer by Potemkin Limited ("Potemkin") to purchase up to 10,000 shares of the Company's common stock. The offer price of $53.00 per share is approximately 34.42 percent lower than the $80.82 per share closing price for the Company's common stock on September 12, 2025. The shares subject to Potemkin's offer represent approximately 0.00002 percent of the shares of the Company's outstanding common stock as of August 31, 2025. The Company does not endorse Potemkin's unsolicited mini-tender offer and is not associated in any way with Potemkin, its mini-tender offer, or its mini-tender offer documents. On September 15, 2025, the Company issued a news release informing its shareholders that the Company does not endorse Potemkin's unsolicited mini-tender offer and recommending that shareholders not tender their shares to Potemkin. Shareholders who have already tendered their shares may withdraw them in the manner described in the Potemkin mini-tender offer documents prior to the expiration of the offer. Potemkin's offer is currently scheduled to expire at 5:00 p.m., Eastern time, on Tuesday, October 7, 2025. Additional information concerning mini-tender offers is included, or referred to, in the news release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. 99.1 News release of MetLife, Inc., dated September 15 , 2025, recommending shareholders reject "mini-tender" offer by Potemkin Limited 101 Pursuant to Rule 406 of Regulation S-T, the cover page is formatted in Inline XBRL (Inline eXtensible Business Reporting Language) 104 Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101) 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. METLIFE, INC. By: /s/ Timothy J. Ring Name: Timothy J. Ring Title: Senior Vice President and Secretary Date: September 15, 2025 3

View Full Filing

View this 8-K filing on SEC EDGAR